Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR -Mutant Non-Small Cell Lung Cancer: A Case Series.
Simple Summary: We describe three women with EGFR-mutant lung cancer in whom a rare ROS1 exon 35–37 RNA-level intragenic rearrangement was detected after progression on EGFR-targeted therapy. Our series demonstrates that combining two different targeted therapies to block both mutations can lead to...
| Publicado en: | Current Oncology Vol. 33; no. 6; pp. 311 - 323 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Jun2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |